Tumor necrosis factor (TNF) can be considered as an alternative for treating MCC because this cytokine displayed a high efficacy in three patients [206,207], and in one patient out of three treated with IFNγ plus TNFα a complete response was noticed, while a partial and no response was observed in two others [208]. Here, IFNG is linked to Merkel cell skin cancer.